Evidence map›Paper›PMID 42582530›Full record

ArticleQuantitative imaging in medicine and surgery2026

Deep meta-learning framework with U-Net segmentation and optimization-based feature selection for breast cancer detection in MRI images.

Balasubramaniam Pudhupalayam Marimuthu, Paulraj Ranjith Kumar, Arivoli Sundaramurthy, Jaya Jayabalan, Nourah Ahmed AlGhamlas, Bader Abdulkareem Alablani, Mohammad Mukhtar Alam, Wee Kuok Kwee

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Balasubramaniam Pudhupalayam MarimuthuHindusthan Institute of Technology, Coimbatore, Tamilnadu, India.
Paulraj Ranjith KumarPSR Engineering College, Sivakasi, Tamilnadu, India.
Arivoli SundaramurthyPSG Institute of Technology and Applied Research, Coimbatore, Tamilnadu, India.
Jaya JayabalanDepartment of Electronics and Communication Engineering, Hindusthan College of Engineering and Technology, Coimbatore, Tamil Nadu, India.
Nourah Ahmed AlGhamlasInfo Systems and Operations Management Department, College of Business Administration, Kuwait University, Kuwait City, Kuwait.
Bader Abdulkareem AlablaniDepartment of Business, Arab Open University, Kuwait City, Kuwait.
Mohammad Mukhtar AlamDepartment of Industrial Engineering, College of Engineering, King Khalid University, Abha, Saudi Arabia.
Wee Kuok KweeCenter for Intelligent Cloud Computing (CICC), COE of Advanced Cloud, Faculty of Information Science & Technology, Multimedia University, Jalan Ayer Keroh Lama, Melaka, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Breast cancer is one of the most prevalent cancers worldwide and continues to pose significant challenges to global healthcare systems. The survival rate of patients largely depends on early detection, accurate diagnosis, and timely treatment. Medical imaging techniques such as mammography, ultrasound, and magnetic resonance imaging (MRI) are widely used for detecting abnormalities in breast tissue. However, many existing breast cancer detection approaches suffer from limitations such as high computational complexity, long tumor detection time, inaccurate predictions, and high false-positive rates. These challenges highlight the need for more reliable and efficient automated diagnostic systems. The aim of this study is to develop an efficient deep meta-learning framework for accurate breast cancer detection and classification using MRI images. The proposed system integrates preprocessing, tumor segmentation, feature extraction, optimization, and deep learning models to improve diagnostic accuracy, reduce false-positive rates, and support early clinical decision-making in computer-aided diagnosis systems. Methods: This work proposes a deep meta-learning framework for precise breast cancer detection and classification using MRI images. The framework integrates multiple stages to improve diagnostic accuracy. Initially, Adaptive Median Filtering (AMF) is applied to enhance image quality and remove noise during preprocessing. Subsequently, U-Net-based segmentation is used to accurately identify tumor regions. Growth Distribution Depth (GDD) is employed to extract discriminative features from the segmented regions, and Salp Swarm Optimization (SSO) is used to select the most relevant features. Finally, deep meta-learning-based classification is performed using pre-trained convolutional neural network (CNN) models, including AlexNet, VGG16, and LeNet, which are fine-tuned on breast cancer datasets to improve classification performance. Results: Experimental results demonstrate that the proposed framework achieves superior performance compared to existing methods. Among the evaluated models, the VGG16-based classifier shows the best performance, achieving an accuracy of 98.82%, precision of 97.1%, recall of 99.11%, and an F1-score of 98.25%. The integration of tumor-focused segmentation and optimization-based feature selection significantly improves classification accuracy and reduces false detections. Conclusions: The proposed deep meta-learning framework provides an effective and reliable approach for automated breast cancer detection from MRI images. By combining advanced preprocessing, segmentation, feature extraction, optimization, and deep learning classification techniques, the framework enhances diagnostic accuracy and efficiency. The results suggest that the proposed method has strong potential to support computer-aided diagnosis systems and assist clinicians in early breast cancer detection.

Indexed as

Adaptive Median Filtering pre-processing (AMF pre-processing)Deep meta-learningGrowth Distribution Depth (GDD)Salp Swarm Optimization (SSO)U-Net-based segmentation

Identifiers

PMID42582530
PMCPMC13458187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.